PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
12-Jun-2020 FDA Approves Pfizer’s Oncology Supportive Care Biosimilar, NYVEPRIA™ (pegfilgrastim-apgf) Pfizer Inc
12-Jun-2020 Sofinnova Partners Announces Sale of Corvidia Therapeutics to Novo Nordisk Novo Nordisk acquires Corvidia for $2.1B with an upfront payment of $725M in cash Sofinnova Partners
12-Jun-2020 Onyx Health Launch VR Learning Platform in Response to COVID-19 Onyx Health
12-Jun-2020 SCOTTISH LIFE SCIENCE COMPANY DEVELOPS COVID-19 ANTIBODY SCREENING TRIALS TO AID QUEST FOR VACCINE DEVELOPMENT Arrayjet Limited
12-Jun-2020 NuCana Announces Re-Opening of Global Phase III Study of Acelarin Plus Cisplatin in Patients with Biliary Tract Cancer (NuTide:121) NuCana
11-Jun-2020 Valmet to supply automation to a gas clean-up system at Viridor’s site in Scotland, UK Valmet
11-Jun-2020 Clean cold experts explore how people in Africa can access COVID-19 vaccine The University of Birmingham
11-Jun-2020 Intravacc and Versatope sign research service agreement to develop universal influenza vaccine based on OMV technology Intravacc and Versatope
11-Jun-2020 First adjuvanted quadrivalent influenza vaccine receives EU approval Intended for medical, pharmaceutical industry and business media Seqirus
11-Jun-2020 Sanofi to present Phase 3 results of avalglucosidase alfa in patients with late-onset Pompe disease Sanofi
11-Jun-2020 Interferon-lambda has potential to reduce transmission of COVID-19, says GlobalData GlobalData
11-Jun-2020 The RSA Group reveals new global brand The RSA Group
11-Jun-2020 The Royal Society of Chemistry’s Emerging Technologies Competition 2020 welcomes entries The Royal Society of Chemistry
11-Jun-2020 LILLY’S IXEKIZUMAB (TALTZ®) RECEIVES EU MARKETING AUTHORISATION FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS (axSpA) Eli Lilly and Company
11-Jun-2020 Roxadustat Demonstrates Non-Inferiority to Darbepoetin in Phase 3 DOLOMITES Study of Anemia in Non-Dialysis-Dependent Adult Patients with Chronic Kidney Disease Astellas Pharma Inc
11-Jun-2020 Roxadustat Demonstrates Non-Inferiority to Darbepoetin in Phase 3 DOLOMITES Study of Anemia in Non-Dialysis-Dependent Adult Patients with Chronic Kidney Disease Astellas Pharma Inc
11-Jun-2020 G42 and ONT Co-Develop Ultra-Scalable Solution for COVID-19 Detection Group 42
11-Jun-2020 Genmab Announces European Marketing Authorization for the Subcutaneous Formulation of DARZALEX® (daratumumab) for the Treatment of Patients with Multiple Myeloma Genmab
11-Jun-2020 NHS Confederation chief executive to step down NHS Confederation
11-Jun-2020 Intravacc partners with Wageningen Bioveterinary Research and Utrecht University to develop an intranasal COVID-19 vaccine Intravacc